share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 15 04:33
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.